Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Xtant Medical Holdings, Inc.XTNT · Entity 7196 | Vice President, Finance & CFO | August 15, 2021 | August 17, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Xtant Medical Holdings, Inc.
Report date August 15, 2021 · Filed August 17, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, $0.000001 par valueSEC Table I · non-derivative | Direct | 285,331 |
Reported balance
After 2021-08-15 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2021-08-15 · Grant · Acquired 156,250 · Balance 285,331 F1: These shares will vest and be issued with respect to 39,062 shares on each of August 15, 2022, August 15, 2023 and August 15, 2024 and with respect to 39,064 shares on August 15, 2025 pursuant to a restricted stock unit granted under the Xtant Medical Holdings, Inc. 2018 Equity Incentive Plan. F2: Includes 244,587 shares that will be issued over time subject to vesting pursuant to restricted stock units granted under the Xtant Medical Holdings, Inc. 2018 Equity Incentive Plan. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.27 · Expires 2031-08-15 | Direct | 192,308 |
Reported balance
After 2021-08-15 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2021-08-15 · Grant · Acquired 192,308 · Balance 192,308 F3: This option vests with respect to 48,077 shares on August 15, 2021 and with respect to the remaining 75% of such shares over the three-year period thereafter in 12 as nearly equal as possible quarterly installments, subject to such Reporting Person's continued employment with Xtant Medical Holdings, Inc. |
Filing footnotes · ownership attribution and instrument terms
F1: These shares will vest and be issued with respect to 39,062 shares on each of August 15, 2022, August 15, 2023 and August 15, 2024 and with respect to 39,064 shares on August 15, 2025 pursuant to a restricted stock unit granted under the Xtant Medical Holdings, Inc. 2018 Equity Incentive Plan.
F2: Includes 244,587 shares that will be issued over time subject to vesting pursuant to restricted stock units granted under the Xtant Medical Holdings, Inc. 2018 Equity Incentive Plan.
F3: This option vests with respect to 48,077 shares on August 15, 2021 and with respect to the remaining 75% of such shares over the three-year period thereafter in 12 as nearly equal as possible quarterly installments, subject to such Reporting Person's continued employment with Xtant Medical Holdings, Inc.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 15, 2021 Filed Aug 17, 2021 20:20 UTC | Xtant Medical Holdings, Inc. XTNT · Entity 7196 | GrantStock Option (right to buy) · Derivative | 192,308 | $0.00 Strike: $1.27 | $0.00 |
DisclosureSEC source: 0001235802-21-000102 · primary_doc.xml · derivative · entry 2 JENSEN GREG · CIK 0001199647 · Vice President, Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 192,308 Underlying: Common Stock · 192,308 shares Expires 2031-08-15 F3 · derivative.exercise_date: This option vests with respect to 48,077 shares on August 15, 2021 and with respect to the remaining 75% of such shares over the three-year period thereafter in 12 as nearly equal as possible quarterly installments, subject to such Reporting Person's continued employment with Xtant Medical Holdings, Inc. Read SEC document |
| August 15, 2021 Filed Aug 17, 2021 20:20 UTC | Xtant Medical Holdings, Inc. XTNT · Entity 7196 | GrantCommon Stock, $0.000001 par value | 156,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001235802-21-000102 · primary_doc.xml · nonDerivative · entry 1 JENSEN GREG · CIK 0001199647 · Vice President, Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 285,331 F1 · shares: These shares will vest and be issued with respect to 39,062 shares on each of August 15, 2022, August 15, 2023 and August 15, 2024 and with respect to 39,064 shares on August 15, 2025 pursuant to a restricted stock unit granted under the Xtant Medical Holdings, Inc. 2018 Equity Incentive Plan. F2 · balance_after: Includes 244,587 shares that will be issued over time subject to vesting pursuant to restricted stock units granted under the Xtant Medical Holdings, Inc. 2018 Equity Incentive Plan. Read SEC document |
| August 15, 2020 Filed Aug 19, 2020 00:24 UTC | Xtant Medical Holdings, Inc. XTNT · Entity 7196 | GrantStock Option (right to buy) · Derivative | 119,942 | $0.00 Strike: $1.13 | $0.00 |
DisclosureSEC source: 0001235802-20-000098 · primary_doc.xml · derivative · entry 2 JENSEN GREG · CIK 0001199647 · VP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,942 Underlying: Common Stock · 119,942 shares Expires 2030-08-15 F3 · derivative.exercise_date: This option vests with respect to 29,986 shares on August 15, 2021 and with respect to the remaining 75% of such shares over the three-year period thereafter in 12 as nearly equal as possible quarterly installments., subject to such Reporting Person's continued employment with Xtant Medical Holdings, Inc. Read SEC document |
| August 15, 2020 Filed Aug 19, 2020 00:24 UTC | Xtant Medical Holdings, Inc. XTNT · Entity 7196 | GrantCommon Stock, $0.000001 par value | 95,183 | $0.00 | $0.00 |
DisclosureSEC source: 0001235802-20-000098 · primary_doc.xml · nonDerivative · entry 1 JENSEN GREG · CIK 0001199647 · VP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,081 F1 · shares: These shares will vest and be issued with respect to 23,796 shares on each of August 15, 2021, August 15, 2022 and August 15, 2023 and with respect to 23,795 shares on August 15, 2024 pursuant to a restricted stock unit granted under the Xtant Medical Holdings, Inc. 2018 Equity Incentive Plan. F2 · balance_after: Includes 120,607 shares that will be issued over time subject to vesting pursuant to restricted stock units granted under the Xtant Medical Holdings, Inc. 2018 Equity Incentive Plan. Read SEC document |
| August 15, 2019 Filed Aug 16, 2019 20:09 UTC | Xtant Medical Holdings, Inc. XTNT · Entity 7196 | GrantStock Option (right to buy) · Derivative | 39,063 | $0.00 Strike: $2.76 | $0.00 |
DisclosureSEC source: 0001235802-19-000103 · primary_doc.xml · derivative · entry 2 JENSEN GREG · CIK 0001199647 · VP, Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,063 Underlying: Common Stock · 39,063 shares Expires 2029-08-15 F2 · derivative.exercise_date: This option vests with respect to 9,765 shares on August 15, 2020 and with respect to 9,766 shares on each of August 15, 2021, August 15, 2022 and August 15, 2023, subject to such Reporting Person's continued employment with Xtant Medical Holdings, Inc. Read SEC document |
| August 15, 2019 Filed Aug 16, 2019 20:09 UTC | Xtant Medical Holdings, Inc. XTNT · Entity 7196 | GrantCommon Stock, $0.000001 par value | 33,898 | $0.00 | $0.00 |
DisclosureSEC source: 0001235802-19-000103 · primary_doc.xml · nonDerivative · entry 1 JENSEN GREG · CIK 0001199647 · VP, Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,898 F1 · shares: These shares will vest and be issued with respect to 8,474 shares on each of August 15, 2020 and August 15, 2021 and with respect to 8,475 shares on each of August 15, 2022 and August 15, 2023 pursuant to a restricted stock unit granted under the Xtant Medical Holdings, Inc. 2018 Equity Incentive Plan. F1 · balance_after: These shares will vest and be issued with respect to 8,474 shares on each of August 15, 2020 and August 15, 2021 and with respect to 8,475 shares on each of August 15, 2022 and August 15, 2023 pursuant to a restricted stock unit granted under the Xtant Medical Holdings, Inc. 2018 Equity Incentive Plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.